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Abstract
Background: Skeletal muscle consists of type-I (slow-twitch) and type-II (fast-twitch) fibers, with
proportions highly variable between individuals and mostly determined by genetic factors. Cross-
sectional studies have associated low percentage of type-I fibers (type-I%) with many cardiovascular
risk factors.
Methods: We investigated whether baseline type-I% predicts left ventricular (LV) structure and
function at 19-year follow-up, and if so, which are the strongest mediating factors. At baseline in
1984 muscle fiber-type distribution (by actomyosin ATPase staining) was studied in 63 healthy men
(aged 32–58 years). The follow-up in 2003 included echocardiography, measurement of obesity
related variables, physical activity and blood pressure.
Results: In the 40 men not using cardiovascular drugs at follow-up, low type-I% predicted higher
heart rate, blood pressure, and LV fractional shortening suggesting increased sympathetic tone.
Low type-I% predicted smaller LV chamber diameters (P ≤ 0.009) and greater relative wall thickness
(P = 0.034) without increase in LV mass (concentric remodeling). This was explained by the
association of type-I% with obesity related variables. Type-I% was an independent predictor of
follow-up body fat percentage, waist/hip ratio, weight gain in adulthood, and physical activity (in all
P ≤ 0.001). After including these risk factors in the regression models, weight gain was the strongest
predictor of LV geometry explaining 64% of the variation in LV end-diastolic diameter, 72% in end-
systolic diameter, and 53% in relative wall thickness.
Conclusion: Low type-I% predicts obesity and weight gain especially in the mid-abdomen, and
consequently unfavourable LV geometry indicating increased cardiovascular risk.
Background
Skeletal muscles consist of two main types of fiber with
different metabolic and functional profiles. Slow-twitch
(type I) muscle fibers have a high capacity for oxidative
energy metabolism, whereas fast-twitch (type II) fibers
have a high capacity for glycolytic energy production [1].
The percentage of slow-twitch type I fibers (type-I%) var-
ies widely among individuals (range 13–96%, mean value
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about 50% to 60%), is mostly genetically determined [2],
and is resistant to training-induced change [3,4]. Individ-
uals with high type-I% are more suited to endurance type
physical activities, whereas those with low type-I% are
better endowed for speed and power type activities [1,5].
This variation in skeletal muscle fiber composition may
make it easier for some people to achieve a high level of
endurance fitness known to favour reduced risk of cardio-
vascular disease. Accordingly, former elite endurance
sport athletes seem to have less cardiovascular disorders
and longer life expectancy than former elite speed and
strength athletes [6]. In cross-sectional studies high type-
I% has been associated with high volume of physical
activity, with fitness, and with a favourable lipid profile
[7], while low type-I% has been found to associate with
obesity [8,9], with insulin resistance [10], and with higher
blood pressure [11].
As cross-sectional studies have shown that skeletal muscle
fiber composition associates with several cardiovascular
risk factors, we hypothesized that the proportion of slow-
twitch skeletal muscle fibers could predict left ventricular
(LV) structure and function. We tested this hypothesis in
a follow-up study of non-athletic men in whom skeletal
muscle fiber composition had been determined 19 years
earlier.
Methods
An invitation to a follow-up study was sent to 79 male
participants of a 1984 baseline study designed to assess
the relationships between skeletal muscle fiber composi-
tion, physical fitness and lipid profile [7,12]. The men
were originally recruited from private companies in Hel-
sinki and had volunteered for the baseline study in
response to the offer of a guided exercise programme
funded by their employers. Their leisure-time physical
activity (LTPA) levels varied from inactive to regular jog-
ging, but none was a competitive athlete. In 2003 four of
the men had died and one had moved abroad and could
not be contacted. Altogether 63 men (85% of those con-
tacted) participated in the follow-up study including
echocardiography. The study was approved by the ethics
committee of the Joint Authority for the Hospital Districts
of Helsinki and Uusimaa. The subjects gave informed con-
sent. The procedures followed were in accordance with
institutional guidelines.
At baseline in 1984 the study subjects were apparently
healthy and taking no long-term medication. Skeletal
muscle fiber distribution was analysed from needle sam-
ples from the lateral portion of the quadriceps femoris
muscle as described in detail earlier [12]. Muscle samples
were stained for actomyosin ATPase, which clearly sepa-
rates the two main fiber types. A personal interview pro-
vided data on LTPA which was expressed as metabolic
equivalents of oxygen consumption (MET), hours/week
[7]. Height and weight were obtained to calculate the
body mass index (BMI) (kg/m2). Weight gain during
adulthood was calculated as the mean yearly change in
BMI after the age of 20. Finnish men know their weight
and height measured during their compulsory military
service at 20 years.
At follow-up in 2003 the age of the 63 men ranged from
51 to 77 years. All measurements and interviews were
made blinded to baseline data. The study included
echocardiography and a 12-lead electrocardiogram. Blood
pressure was measured twice in each individual after a
five-minute rest and the value with lower mean pressure
was recorded. BMI and waist/hip ratio were measured and
weight gain since 20 years of age was calculated. Body fat
percentage was evaluated based on four skin fold meas-
urements (subscapular, triceps brachii, biceps brachii, and
crista iliaca) with calliper [13]. Volume of LTPA, use of
Table 1: Characteristics of men with low and high percentage of slow-twitch type-I skeletal muscle fibers.
Type-I% ≤60% 
(n = 20)
Type-I% >60% 
(n = 20)
P
Age (years) 57.4 (4.8) 60.5 (7.2) 0.11
Type-I% 47.6 (10.6) 71.6 (7.8) <0.001
BMI at the age of 20 (kg/m2) 21.7 (1.5) 21.8 (2.0) 0.90
BMI in 1984 (kg/m2) 24.1 (2.9) 22.4 (2.6) 0.05
BMI in 2003 (kg/m2) 27.5 (4.4) 24.0 (3.3) 0.007
Weight gain/year (kg/m2) until 2003 0.16 (0.11) 0.06 (0.06) 0.002
Waist/hip ratio in 2003 1.00 (0.005) 0.94 (0.006) 0.002
Body fat % in 2003 25.5 (5.0) 19.4 (4.2) <0.001
LTPA in 2003 (MET) 26.5 (17.1) 42.6 (23.9) 0.019
Alcohol consumption (g/day) in 2003 14.3 (9.4) 16.7 (14.7) 0.55
Values are mean (SD). BMI = body mass index, LTPA = leisure time physical activity. Weight gain was calculated as the mean yearly change in BMI 
after the age of 20.BMC Cardiovascular Disorders 2006, 6:2 http://www.biomedcentral.com/1471-2261/6/2
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medication and use of alcohol were assessed by personal
interview and questionnaire. Alcohol use was recorded as
frequency and quantity of different beverage types, and
converted into grams of absolute alcohol per day.
Echocardiography
Studies were performed with an Acuson 128 instrument
by the same experienced observer blinded to other data.
LV cavity dimensions and septal and posterior wall thick-
ness were measured from an enlarged M-mode image
directly from the screen monitor. In case optimal orienta-
tion of M-mode beam could not be obtained, measure-
ments were taken from two-dimensional images [14] with
the aid of harmonic imaging software, if necessary. LV
mass was calculated using the formula by Devereux [15].
LV mass and dimensions were also indexed for body sur-
face area. Concentricity of the LV myocardium was esti-
mated by calculating the relative wall thickness: Relative
wall thickness = (septal thickness + posterior wall thick-
ness)/LV end-diastolic diameter. LV systolic function was
evaluated by calculating the percentage of fractional short-
ening of the LV endocardium: Fractional shortening% =
(end-diastolic diameter – end-systolic diameter)/end-
diastolic diameter*100.
Statistical methods
The analyses were designed to test the hypothesis that
type-I% muscle fiber composition, assessed at baseline in
1984, would predict LV structure and function measured
at follow-up in 2003, and if so, to investigate the strongest
mediating factors. We first compared the findings in men
with low type-I% (≤60% = below median) and high type-
I% (>60% = above median), and tested the differences
with the t-test. Based on Pearson's bivariate correlations
between the variables, multivariate linear regression mod-
els were used. Follow-up age was included first in all
regression models. First, dependence of echocardio-
graphic indices on type-I% was analysed one-by-one. Sec-
ond, dependence of the different cardiac risk factors at
baseline (LTPA in 1984, BMI in 1984, and adulthood
weight gain until 1984) and at follow-up (obesity related
variables, LTPA, systolic and diastolic blood pressure, and
heart rate) on type-I% was analysed one-by-one. Third, in
separate stepwise regression models baseline and follow-
up cardiac risk factors were added to test which of the risk
factors had the strongest impact on echocardiographic
indices. All P-values were based on a two-sided alternative
hypothesis. Statistical analyses were performed with SPSS
11.5 for Windows software.
Table 3: Percentage of slow-twitch type-I muscle fibers as a predictor of echocardiographic indices at follow-up.
Dependent variable Regression coefficient B
(95% confidence interval)
P-value R square
LV end-diastolic diameter (mm/m2) 0.093 (0.024 to 0.162) 0.009 0.23
LV end-systolic diameter (mm/m2) 0.097 (0.039 to 0.156) 0.002 0.30
LV mean wall thickness (mm/m2) -0.002 (-0.017 to 0.012) 0.768
Relative wall thickness -0.002 (-0.003 to 0.000) 0.034 0.12
LV mass (g/m2) -0.055 (-0.581 to 0.470) 0.833
Fractional shortening (%) -0.150 (-0.240 to -0.059) 0.002 0.30
Results are adjusted for age.
Table 2: Cardiovascular findings at follow-up in men with low and high percentage of slow-twitch type I skeletal muscle fibers.
Type I fibers ≤60%
(n = 20)
Type I fibers >60%
(n = 20)
P
Heart rate (beats/min) 64 (10) 55 (9) 0.006
Systolic blood pressure (mmHg) 144 (21) 138 (19) 0.35
Diastolic blood pressure (mmHg) 91 (8) 85 (7) 0.016
LV end-diastolic diameter (mm) 51.6 (4.6) 53.9 (4.3) 0.13
LV end-diastolic diameter (mm/m2) 25.1 (3.1) 28.3 (3.1) <0.001
LV end-systolic diameter (mm) 31.7 (4.1) 35.8 (3.9) 0.003
LV end-systolic diameter (mm/m2) 15.4(2.7) 18.8 (2.5) <0.001
Mean LV wall thickness (mm) 10.8 (1.7) 10,2 (1.2) 0.25
Mean LV wall thickness (mm/m2) 5.2 (0.7) 5.4 (0.6) 0.42
LV mass (g) 215 (52) 216 (52) 0.95
LV mass (g/m2) 104 (22) 112 (25) 0.22
Relative wall thickness 0.42 (0.009) 0.38 (0.05) 0.07
LV fractional shortening (%) 38.7 (4.3) 33.7 (3.7) <0.001
Values are mean (SD). LV = left ventricleBMC Cardiovascular Disorders 2006, 6:2 http://www.biomedcentral.com/1471-2261/6/2
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Results
In 1984 none of the 63 subjects were on chronic medica-
tion, but 19 years later 22 men (35%) used cardiovascular
drugs (beta blockers, angiotensin-convertase enzyme
inhibitors, angiotensin receptor antagonists, calcium
blockers, or diuretics). Men with low type-I% used these
drugs more often (47%) than those with high type-I%
(23%) (P = 0.053, Chi-square test). Because these drugs
influence LV structure and blood pressure, men using
them were excluded from the final analysis. In addition to
men with treated hypertension this excluded also 5 men
with valve disease, sequelae of myocardial infarction, and
atrial fibrillation. One man not using drugs was found to
have cardiomyopathy with an ejection fraction of 33%
and left bundle branch block and was excluded. Thus the
final analysis included 40 men in whom type-I% varied
from 23% to 88 % with a mean value of 59.6% (Table 1).
Comparison of men with low and high type-I%
There was no difference in BMI at 20 years between the
groups (Table 1), but at follow-up men with low type-I%
had gained more weight being 13.1 kg heavier on average.
LTPA was 61% higher at follow-up in the high type-I%
group and did not differ significantly from LTPA at base-
line in either group. Table 2 shows the echocardiograhic
findings in men with low and high type-I%. LV mass,
whether indexed for body surface area or not, did not dif-
fer between the groups. Men with low type-I% had smaller
chamber diameters especially if indexed for body surface
area, but their mean wall thickness did not differ. This
resulted in 11% greater relative wall thickness and more
concentric LV myocardium. In addition to higher blood
pressure, men with low type-I% also had signs of more
hyperdynamic systolic function of the LV; fractional short-
ening was 15% and heart rate 16% higher.
Type-I% as a predictor of echocardiographic indices
In regression models low type-I% predicted smaller LV
with increased relative wall thickness (concentric remode-
ling) and greater fractional shortening. (Table 3, Fig. 1).
Type-I%, age, LTPA, and weight gain at baseline
Age did not associate with type-I%. Lower type-I% pre-
dicted greater weight gain after the age of 20 until baseline
in 1984, explaining 27% of its variation. Type-I% also
associated with baseline LTPA, explaining alone 39% of
its variation and together with age 52% (Table 4). Type-
I% was the only significant predictor of weight gain if
both type-I% and LTPA were included as independent var-
iables in the same model.
Type-I% and cardiac risk factors at follow-up
Pearson's bivariate correlations showed that type-I% had
close interrelations with LTPA in 2003 (R = 0.56, P  <
0.001), and with variables related to obesity (for BMI R =
-0.47, P = 0.002; for waist/hip ratio R = -0.55, P =< 0.001;
for body fat percentage R = -0.65, P  < 0.001; and for
weight gain R = -0.52, P = 0.001). All obesity-related vari-
ables were predicted by type-I% in regression analysis
adjusted for age (Table 4, Fig. 2). Body fat percentage asso-
ciated also with LTPA in 2003. Low type-I% also inde-
pendently predicted higher diastolic blood pressure and,
in addition to age, higher systolic blood pressure.
Type-I%, cardiac risk factors and echocardiographic 
indices
When baseline cardiac risk factors (LTPA 1984, and
weight gain 1984 or BMI 1984) were added stepwise into
the model, adulthood weight gain 1984 significantly
improved the explanatory rate of the model for LV diasto-
lic (P = 0.006, R2 = 0.38) and systolic (P = 0.004, R2 =
Table 4: Percentage of slow-switch type-I muscle fibers as a predictor of cardiac risk factors at baseline and at follow-up
Dependent variable Regression coefficient B
(95% confidence interval)
P-value R square
Baseline 1984
Body mass index (kg/m2) -0.085 (-0.144 to -0.027) 0.005 0.19
Weight gain (kg/m2/year) -0.005 (-0.007 to -0.002) 0.001 0.27
Physical activity (MET) 1.098 (0.588 to 1.607) <0.001 0.52
Follow-up 2003
Body mass index (kg/m2) -0.134 (-0.218 to -0.051) 0.002 0.23
Weight gain (kg/m2/year) -0.003 (-0.005 to -0.001) 0.001 0.29
Waist/hip ratio -0.002 (-0.003 to -0.001) 0.001 0.30
Body fat (%) -0.223 (-0.316 to -0.130) <0.001 0.45
Physical activity (MET) 0.823 (0.409 to 1.238) <0.001 0.31
Systolic blood pressure (mmHg) -0.460 (-0.858 to -0.061) 0.025 0.23
Diastolic blood pressure (mmHg) -0.261 (-0.419 to -0.103) 0.002 0.24
Heart rate (beats/min) -0.322 (-0.542 to -0.102) 0.005 0.20
Results are adjusted for age. Age was a significant predictor of physical activity in 1984 (B = 1.937, 95%CI 0.693 to 3.182, P = 0.003), and systolic 
blood pressure at follow-up (B = 1.397, 95%CI 0.424 to 2.370, P = 0.006)
Weight gain was calculated as mean yearly change in body mass index after the age of 20.BMC Cardiovascular Disorders 2006, 6:2 http://www.biomedcentral.com/1471-2261/6/2
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Scatterplots showing the association of percentage of type-I  fibers with weight gain in adulthood, with body fat percent- age, and with middle body obesity at follow-up Figure 2
Scatterplots showing the association of percentage of type-I 
fibers with weight gain in adulthood, with body fat percent-
age, and with middle body obesity at follow-up.
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Scatterplots showing the association of percentage of type-I  fibers at baseline with left ventricular dimensions indexed for  body surface area and with relative wall thickness at follow- up Figure 1
Scatterplots showing the association of percentage of type-I 
fibers at baseline with left ventricular dimensions indexed for 
body surface area and with relative wall thickness at follow-
up.
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0.45) dimensions and relative wall thickness (P = 0.001,
R2 = 0.37). Type-I% remained, however, an independent
predictor of systolic LV function (P = 0.002, R2 = 0.30).
The cross-sectional impact of follow-up risk factors on
echocardiographic indices is shown in Table 5. Weight
gain until 2003 had a strong negative association with
indexed LV dimensions and a positive association with
relative wall thickness and thus with concentric remode-
ling (Fig. 3). The strongest predictor of LV fractional short-
ening was body fat percentage.
We performed similar regression analyses also in the
whole study group including the men using cardiovascu-
lar drugs with comparable results: Type-I% predicted LV
chamber diameters and systolic function (P  < 0.001–
0.009), but not LV wall thickness or LV mass. Type-I%
also predicted follow-up LTPA (P < 0.001) and obesity
related variables (P = 0.002–0.014). After including the
follow-up risk factors in the regression models weight
gain was again the strongest predictor of LV diameters and
relative wall thickness (in all P < 0.001) but also type-I%
remained a significant predictor for LV endsystolic diam-
eter (P = 0.004) and fractional shortening (P < 0.001).
Discussion
Skeletal muscles, representing 35–45% of body mass, play
a central role in whole-body energy metabolism [1]. Our
follow-up study shows that the fiber composition of skel-
etal muscles, which dictates their metabolic and oxidative
profile, is profoundly associated with cardiovascular risk
factors and consequently with unfavorable LV geometry.
All such disadvantageous findings seem to accumulate in
men with a low percentage of slow-twitch type I muscle
fibers.
In our study type-I% at baseline predicted follow-up BMI,
waist/hip ratio, fatness and weight gain in adulthood,
confirming earlier cross-sectional findings [8,9]. Interest-
ingly, our subjects' BMI at the age of 20 had no relation-
ship with the type-I%. However, 12–38 years later at
baseline in1984 this association was already clear and at
follow-up in 2003 even stronger (Table 1 and 4). Greater
weight gain in subjects with low type-I% may be linked to
the hampered ability of skeletal muscle to oxidize lipid
[16]. Weight loss interventions have been more successful
in obese women with higher type-I% compared with
those having low type-I% [9]. Further, lean men with high
type-I% consume more fat during similar exercise inten-
sity than obese men with lower type-I% [8]. In our study
type-I% also associated closely with volume of LTPA both
at baseline and follow-up, which would partly explain the
lesser extent of fatness in high type-I% men. Thus it would
seem that obesity resistance in high type-I% subjects is
due to both the metabolic properties of the muscle and to
the propensity for high level physical activity.
Low type-I% also independently predicted higher blood
pressure as we have reported in detail earlier [17]. Further,
heart rate and fractional shortening of the left ventricle
were also higher in low type-I% men, largely explained by
greater obesity-related variables in these men. Together,
these findings may reflect increased sympathetic tone in
low type-I% subjects, as has also been suggested by others
[18].
Low type-I% predicted concentric remodeling of the left
ventricle. The impact of low type-I% was, however, mostly
mediated by an increase in BMI (Table 4 and 5). Cross-
sectional studies have earlier associated obesity with con-
centric LV remodeling in young women [19] and in
healthy adolescents [20], while eccentric LV hypertrophy
has been described in morbid obesity [21]. We found a
strong association between LV geometry and weight gain
(Fig. 3) although in most of our overweight men their
obesity was quite modest. This relationship was clear-cut
despite the exclusion of men with drug therapy for cardi-
ovascular disorders. Concentric LV remodeling is a sign of
arterial stiffening [22] and associates with carotid artery
Table 5: Predictors of echocardiographic indices, with follow-up risk factors included stepwise into the model. Percentage of type-I 
fibers, blood pressure, physical activity, heart rate, and one obesity-related variable were the independent variables.
Dependent variable Strongest follow-up
variables entering the 
model
Regression coefficient B
(95% confidence interval)
P-value R square
LV end-diastolic diameter (mm/m2) Weight gain 2003 -25.64 (-33.74 to -17.53) <0.001 0.64
LV end-systolic diameter (mm/m2) Weight gain 2003 -22.99 (-29.40 to -16.59) <0.001 0.72
LV mean wall thickness (mm/m2)N o n e
Relative wall thickness Weight gain 2003 0.526 (0.333 to 0.718) <0.001 0.53
LV mass (g/m2)N o n e
Fractional shortening (%) Body fat % 0.603 (0.347 to 0.859) <0.001 0.57
Results are adjusted for age. LV = left ventricle.
Weight gain was calculated as mean yearly change in body mass index after the age of 20BMC Cardiovascular Disorders 2006, 6:2 http://www.biomedcentral.com/1471-2261/6/2
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intima-media thickness [23], a highly heritable surrogate
marker of atherosclerosis. It is believed that variation in
each of multiple cardiovascular candidate genes exerts a
small effect on the development of atherosclerosis [24].
Genes regulating the expression of skeletal muscle fibers
[4] seem to be such candidates. Indeed, Wang and cow-
orkers [25] genetically induced a fiber switch to type I in
mice by targeted expression of an activated form of perox-
isome proliferator-activated receptor δ in skeletal muscle,
a major transcriptional regulator of fat burning. Com-
pared to littermates these mice were resistant to obesity
and had high endurance fitness, like our men with high
type-I%. Further, Wisloff and coworkers [26] found that
cardiovascular risk factors emerged in rats after artificial
selection for low intrinsic aerobic capacity. Low capacity
rats had lower peroxisome profilerator-activated receptor
levels than high capacity rats in their soleus muscle,
known to be rich in type I fibers; they also weighed more,
had increased visceral weight, higher blood pressure and
a tendency to shorter and wider myocardial cells. These
observations are consistent with our findings in men with
low type-I%.
The limited sample size study caused a statistical power
limitation in designing multivariate analyses. Only the
strongest pathways mediating associations between mus-
cle fiber type and echocardiographic measurements could
be identified: of these, body fat accumulation/weight gain
was predominant. Our study subjects were white men,
thus our findings may not be applicable to other ethnic
groups or women. Another limitation of our study was
that the measurement of muscle fiber distribution was not
repeated at follow-up. Thus we have no direct evidence
that the distribution of fiber types was the same as at base-
line. However, aging has not been found to change the
percentage of type I fibers [27]. We studied only the main
muscle fiber types I and II.
Type II fibers can be further classified by ATPase staining
into IIa, IIb, and IIx fibers. Resistance- and endurance
training, aging and obesity may induce transformation
between subtypes of II fibers, and in small mammals
training may also induce a switch to type I muscle fibers
[4,28]. Humans do not, however, exhibit increased
expression of type-I muscle fibers with either endurance
or strength training [3,4,29]. Nevertheless, they do exhibit
significant increases in oxidative capacity in all fiber types
with endurance training [4]. Therefore we believe that
endurance training is especially important for subjects
born with low type-I%. This could assist in weight control
and subsequently decrease cardiovascular risks.
Scatterplots showing the association of weight gain in adult- hood with left ventricular dimensions indexed for body sur- face area and with relative wall thickness Figure 3
Scatterplots showing the association of weight gain in adult-
hood with left ventricular dimensions indexed for body sur-
face area and with relative wall thickness.
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Conclusion
We conclude that low proportion of type I muscle fibers
predicts obesity and weight gain especially in the mid-
abdomen, and consequently unfavorable LV geometry,
concentric remodeling. Skeletal muscle fiber composition
seems to be an important background contributor to car-
diovascular risk factors.
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